Correction to: Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan.

Autor: Takahashi, Shunji, Tahara, Makoto, Ito, Koichi, Tori, Masayuki, Kiyota, Naomi, Yoshida, Katsutoshi, Sakata, Yukinori, Yoshida, Akira
Zdroj: Advances in Therapy; Sep2021, Vol. 38 Issue 9, p4989-4993, 5p
Databáze: Complementary Index
Externí odkaz: